442 related articles for article (PubMed ID: 2908303)
1. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
2. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
Tham TC; Guy S; McDermott BJ; Shanks RG; Riddell JG
Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of carvedilol.
Tomlinson B; Prichard BN; Graham BR; Walden RJ
Clin Investig; 1992; 70 Suppl 1():S27-36. PubMed ID: 1350481
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Hashimoto H; Tanaka M; Kanda A; Akashi A
Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S81-4. PubMed ID: 2454374
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of carvedilol in normal volunteers.
Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
Clin Pharmacol Ther; 1987 Jan; 41(1):31-44. PubMed ID: 3802704
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Riddell JG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
Giannattasio C; Cattaneo BM; Seravalle G; Carugo S; Mangoni AA; Grassi G; Zanchetti A; Mancia G
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S18-22. PubMed ID: 1378144
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
Sponer G; Bartsch W; Strein K; Müller-Beckmann B; Böhm E
J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
14. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
[TBL] [Abstract][Full Text] [Related]
16. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
Smith EF; Slivjak MJ; Gagnon R
Cardiovasc Drugs Ther; 1992 Oct; 6(5):499-504. PubMed ID: 1360255
[TBL] [Abstract][Full Text] [Related]
17. Beta blockade by oral propranolol and labetalol.
Cubeddu LX; Carr ME; Fuenmayor NJ
Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation.
Ruffolo RR; Sauermelch CF; Willette RN
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S112-4. PubMed ID: 1974499
[TBL] [Abstract][Full Text] [Related]
20. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
